Nortriptyline
Brand names: Allegron
Nortriptyline is a secondary-amine tricyclic antidepressant also used for neuropathic pain; this page covers its use in older people, in whom it is one of the better-tolerated tricyclics but still carries notable risk.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits reuptake of noradrenaline (and to a lesser extent serotonin) at the synapse, and is relatively less sedating and less anticholinergic than amitriptyline.
Prescribing in practice
- In older people start low and titrate slowly, as anticholinergic effects, postural hypotension, sedation and cardiac conduction effects raise the risk of falls, confusion and arrhythmia.
- Avoid or use with great caution in those with cardiac conduction disease, recent myocardial infarction or significant arrhythmia, and consider a baseline ECG where indicated.
- It is dangerous in overdose; assess suicide risk and consider limiting quantities supplied.
Monitoring
Monitor mood and suicidal ideation early in treatment, plus blood pressure, anticholinergic burden and cardiac status in older patients.
Counselling the patient
- It may take several weeks to improve mood or pain, and the dose is built up gradually.
- Report fainting, palpitations, marked dry mouth, constipation or urinary difficulty.
- Rise slowly from sitting or lying to reduce dizziness.
Evidence & guidelines
NICE recommends tricyclics such as nortriptyline among first-line options for neuropathic pain, with cautious use and slow titration in older adults.
Reference: NICE CG173 (Neuropathic Pain); AGS Beers Criteria 2023; ACB Scale; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5